Search Results

Part of a family of prescription drugs known as incretin mimetics, Onglyza (saxagliptin) and Kombiglyze XR (saxagliptin and metformin HCl) are used to treat Type 2 diabetes. But new data suggests that taking Onglyza or Kombiglyze XR may increase the risk of pancreatic cancer, thyroid cancer, and heart failure, a fatal condition in which the heart can’t pump enough blood (more...)

Invokana (canagliflozin), Invokamet (canagliflozin and metformin), and Invokamet XR (canagliflozin and metformin hydrochloride extended-release) are prescription drugs used in the treatment of Type 2 diabetes. But patients who take these drugs may face an increased risk of developing serious illnesses, including Fournier’s Gangrene, bladder cancer, and renal cancer. You may be entitled to compensation if you lost a loved one who took (more...)

Prescription medications designed to treat Type 2 diabetes work by stimulating the release of certain chemicals in the brain, pancreas, and bloodstream to improve blood glucose levels in the body. These diabetes drug medications also reduce insulin resistance in the liver. Scientific studies have linked several Type 2 diabetes drugs to serious side effects, such as heart attacks, certain types (more...)

Patients with Type 2 diabetes may be prescribed Byetta (exenatide) or Januvia (sitagliptin) to help improve their blood sugar levels in combination with diet and exercise. While both of these popular diabetes drugs work in different ways to achieve their intended results, they share a common link to serious pancreatic problems in certain patients, such as pancreatic cancer. At Ferrer (more...)